Serum albumin modified by carbamoylation impairs macrophage cholesterol efflux in diabetic kidney disease. de Araujo Lira AL, de Fatima Mello Santana M, de Souza Pinto R, Minanni CA, et al. J Diabetes Complications 2021 May 28:107969.

Read + Share

Amedeo Smart

Independent Medical Education

de Araujo Lira AL, de Fatima Mello Santana M, de Souza Pinto R, Minanni CA, et al. Serum albumin modified by carbamoylation impairs macrophage cholesterol efflux in diabetic kidney disease. J Diabetes Complications 2021 May 28:107969.
PMID: 34183248